Q2 2026 report
Spółka przedprzychodowa (NewConnect) rozwijająca urządzenie do pomiaru poziomu cukru (Diabetomat) oraz technologię analizy oddechu (CardioBreath) — obecnie bez istotnych przychodów operacyjnych.
Sentiment
Neutral
No guidance change
AME
Q2 2026 report
Revenue
1,200 PLN
— YoY
Net income
3,482 PLN
— YoY
EBITDA
-2,133 PLN
— YoY
FCF
-151,405 PLN
— YoY
Summary
Investment thesis
- Cały wynik netto pochodzi z przychodów odsetkowych od gotówki na koncie, nie z działalności operacyjnej.
- Stan gotówki spadł o 83% r/r (z 993,5 tys. zł do 168 tys. zł) przy kwartalnym burnie operacyjnym rzędu 150-225 tys. zł — kluczowe ryzyko płynnościowe.
- Zero zadłużenia odsetkowego, finansowanie oparte na kapitale własnym i doraźnych dotacjach (214 tys. zł w Q2 2026).
- Po dniu bilansowym spółka nabyła pełnię praw do patentów Diabetomatu od głównego akcjonariusza — porządkuje strukturę IP przed planowaną komercjalizacją.
Read the full analysis
Financial data is open to everyone. The full analysis — management verdict, commentary, risks, and the full narrative — is available after you sign up or log in.
Financials
BETA
AME · Q2 2026
| Metric | Q2 2026 | Q2 2025 | Δ YoY | YTD 2026 | Δ YoY | Value type | Segment | Conf. |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,200 | — | — | 1,500 | — | reported | — | 1.00 |
| EBITDA | -2,133 | — | — | -1,834 | — | derived | — | 0.90 |
| EBIT | -2,133 | — | — | -1,834 | — | reported | — | 1.00 |
| EBT | 4,032 | — | — | 5,306 | — | reported | — | 1.00 |
| Net income | 3,482 | — | — | 4,756 | — | reported | — | 1.00 |
| D&A | — | — | — | 0 | — | reported | — | 0.90 |
| Income tax | 550 | — | — | 550 | — | reported | — | 1.00 |
| EBITDA margin | -177.76% | — | — | -122.24% | — | reported | — | 0.50 |
| EBIT margin | -177.76% | — | — | -122.24% | — | reported | — | 0.50 |
| Net margin | 290.2% | — | — | 317.04% | — | reported | — | 0.50 |
| Cash | 168,021 | — | — | — | — | reported | — | 1.00 |
| Total debt | 0 | — | — | — | — | reported | — | 1.00 |
| Net debt | -168,021 | — | — | — | — | derived | — | 1.00 |
| Equity | 3,487,463 | — | — | — | — | reported | — | 1.00 |
| Total assets | 3,867,636 | — | — | — | — | reported | — | 1.00 |
| Working capital | -154,265 | — | — | — | — | reported | — | 1.00 |
| Current assets | 225,908 | — | — | — | — | reported | — | 1.00 |
| Current liabilities | 380,173 | — | — | — | — | reported | — | 1.00 |
| Non-current liabilities | 0 | — | — | — | — | reported | — | 1.00 |
| Inventory | 0 | — | — | — | — | reported | — | 1.00 |
| Trade receivables | 738 | — | — | — | — | reported | — | 1.00 |
| Trade payables | 53,168 | — | — | — | — | reported | — | 1.00 |
| Goodwill | 37,750 | — | — | — | — | reported | — | 1.00 |
| CFO | -151,405 | — | — | -376,594 | — | reported | — | 1.00 |
| CapEx | — | — | — | 0 | — | reported | — | 1.00 |
| FCF | -151,405 | — | — | -376,594 | — | derived | — | 1.00 |
| Current ratio | 0.59x | — | — | — | — | reported | — | 1.00 |
| Quick ratio | 0.59x | — | — | — | — | reported | — | 1.00 |
| Cash ratio | 0.44x | — | — | — | — | reported | — | 1.00 |
| Debt / equity | 0x | — | — | — | — | reported | — | 1.00 |
| Debt / assets | 0x | — | — | — | — | reported | — | 1.00 |
| Net debt / equity | -0.05x | — | — | — | — | reported | — | 1.00 |
| Revenue growth (YoY) | 300% | — | — | 150% | — | reported | — | 0.90 |
| EBIT growth (YoY) | — | — | — | -556.99% | — | reported | — | 0.70 |
| Net income growth (YoY) | 161.2% | — | — | -48.3% | — | reported | — | 0.90 |
Q2 2026 · Δ YoY
Revenue
1,200
—
1,200
—
- Q2 2025
- —
- YTD 2026
- 1,500
- Δ YoY
- —
EBITDA
-2,133
—
-2,133
—
- Q2 2025
- —
- YTD 2026
- -1,834
- Δ YoY
- —
EBIT
-2,133
—
-2,133
—
- Q2 2025
- —
- YTD 2026
- -1,834
- Δ YoY
- —
EBT
4,032
—
4,032
—
- Q2 2025
- —
- YTD 2026
- 5,306
- Δ YoY
- —
Net income
3,482
—
3,482
—
- Q2 2025
- —
- YTD 2026
- 4,756
- Δ YoY
- —
D&A
—
—
—
—
- Q2 2025
- —
- YTD 2026
- 0
- Δ YoY
- —
Income tax
550
—
550
—
- Q2 2025
- —
- YTD 2026
- 550
- Δ YoY
- —
EBITDA margin
-177.76%
—
-177.76%
—
- Q2 2025
- —
- YTD 2026
- -122.24%
- Δ YoY
- —
EBIT margin
-177.76%
—
-177.76%
—
- Q2 2025
- —
- YTD 2026
- -122.24%
- Δ YoY
- —
Net margin
290.2%
—
290.2%
—
- Q2 2025
- —
- YTD 2026
- 317.04%
- Δ YoY
- —
Cash
168,021
—
168,021
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Total debt
0
—
0
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Net debt
-168,021
—
-168,021
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Equity
3,487,463
—
3,487,463
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Total assets
3,867,636
—
3,867,636
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Working capital
-154,265
—
-154,265
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Current assets
225,908
—
225,908
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Current liabilities
380,173
—
380,173
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Non-current liabilities
0
—
0
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Inventory
0
—
0
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Trade receivables
738
—
738
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Trade payables
53,168
—
53,168
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Goodwill
37,750
—
37,750
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
CFO
-151,405
—
-151,405
—
- Q2 2025
- —
- YTD 2026
- -376,594
- Δ YoY
- —
CapEx
—
—
—
—
- Q2 2025
- —
- YTD 2026
- 0
- Δ YoY
- —
FCF
-151,405
—
-151,405
—
- Q2 2025
- —
- YTD 2026
- -376,594
- Δ YoY
- —
Current ratio
0.59x
—
0.59x
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Quick ratio
0.59x
—
0.59x
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Cash ratio
0.44x
—
0.44x
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Debt / equity
0x
—
0x
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Debt / assets
0x
—
0x
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Net debt / equity
-0.05x
—
-0.05x
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Revenue growth (YoY)
300%
—
300%
—
- Q2 2025
- —
- YTD 2026
- 150%
- Δ YoY
- —
EBIT growth (YoY)
—
—
—
—
- Q2 2025
- —
- YTD 2026
- -556.99%
- Δ YoY
- —
Net income growth (YoY)
161.2%
—
161.2%
—
- Q2 2025
- —
- YTD 2026
- -48.3%
- Δ YoY
- —